← Back
Data updated: Mar 29, 2026
SAGENT
GastroenterologyCardiovascular
Generics
SAGENT is a generic drug manufacturer focused on Gastroenterology, Cardiovascular. Key products include NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE.
1995
Since
11
Drugs
-
Trials
100
Approved (2yr)
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Recent Activity
DILTIAZEM HYDROCHLORIDE 2026-02-23
Labeling
DILTIAZEM HYDROCHLORIDE 2026-02-23
Labeling
GLYCOPYRROLATE 2026-02-10
Labeling
GLYCOPYRROLATE 2026-02-06
Labeling
NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE 2026-02-06
Manufacturing (CMC)
BUMETANIDE 2026-02-05
DILTIAZEM HYDROCHLORIDE 2026-01-24
Labeling
DILTIAZEM HYDROCHLORIDE 2026-01-24
Labeling
SEC Filings
Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Gastroenterology 67%
2 drugs
Cardiovascular 33%
1 drugs
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Competitors by Therapeutic Area
Active (6)
Discontinued (5)
Company Info
- First Approval
- 1995-01-27
- Latest
- 2025-12-30
- Applications
- 14